Related Experiment Video

Updated: Aug 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Prostate cancer immunology: biology, therapeutics, and challenges

W Scott Webster1, Eric J Small, Brian I Rini

  • 1Department of Urology, Mayo Clinic and Mayo Medical School, 200 1st St SW, Rochester, MN 55905, USA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|November 10, 2005
PubMed

Insights

New immunotherapies show promise for advanced prostate cancer by boosting T-cell responses and manipulating immune cells. Further research is needed to overcome limitations and establish immunotherapy as a leading treatment.

Area of Science:

  • Oncology
  • Immunology
  • Urology

Background:

  • Advanced prostate cancer remains a significant clinical challenge.
  • Current treatment options have limitations, necessitating novel therapeutic strategies.
  • Immunotherapy offers a promising avenue for treating prostate cancer.

Purpose of the Study:

  • To review recent advancements in prostate cancer immunotherapy.
  • To discuss the mechanisms underlying these novel approaches.
  • To identify current limitations and future directions for immunotherapy in prostate cancer.

Main Methods:

  • Review of recent scientific literature on prostate cancer immunotherapy.
  • Analysis of strategies for enhancing antigen-specific T-cell activation.
  • Examination of co-regulatory receptor manipulations for immune cell activity.

Main Results:

  • Several promising immunotherapy approaches are under investigation.
  • Strategies focus on increasing T-cell activation against prostate tumors.
  • Manipulation of co-regulatory receptors aims to prolong immune cell function.

Conclusions:

  • Immunotherapy holds significant potential for advanced prostate cancer treatment.
  • Understanding the mechanistic basis is crucial for therapeutic development.
  • Addressing current limitations is essential to advance immunotherapy's role.

More Related Videos

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...